Scientists Plan To Eradicate The Prostate Cancer Using Novel Genetic Test

For establishing a remarkable prostate cancer screening service, a team of UK-based scientists took an initiative. According to them, the genetic tests will be conducted to check the prostate cancer vulnerability among common during the early stages.

This innovative method can significantly help tackle the nation’s commonly diagnosed cancer. This approach is equivalent to the breast cancer screening program. Each year, over 47500 prostate cancer patients are treated. However, in rare cases, the fatalities count per day surpasses 11,500. This national screening service involves thorough examination of the prostate cancer patients’ saliva to test the genetic susceptibility, which would help in declining the count of cases and mortalities. For leading the research based on the prostate cancer testing and screening service, a decision was granted by Rosalind Eeles, a professor at the Institute Of Cancer Research (ICR).

Eeles told that the research is aimed to discover specific gene variants that make people vulnerable to the prostate cancer. These gene diagnostic tests will not only be the easiest approach to administer the disease but can also be accessible to everyone. Eeles along with her colleagues has disclosed the statistics while establishing the program of prostate cancer testing in NHS. The group noticed all the modifications which led to prostate cancer and also identified measures to uncover the same.

Eeles stated that with the growing age, the rate of prostate cancer increases rapidly. Hence, the researchers are aiming to precisely identify the level of threat for prostate cancer patients. Multiple researches have concluded that nearly 200 different alternatives can elevate prostate cancer risks. The majority of the alternatives can cause a little threat while the remaining generates higher risks. She finds that adults and elderly people are likely to be at higher risk of having prostate cancer, according to the genetic conditions.

The main aim of the program is to provide information regarding the risk of prostate cancer through secure sources and how it can be detected through the prostate cancer care pathway. Eeles highlights that this screening consumes time to gain accuracy and would have to be affordable and easy to use.